Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Voluntary Vs Statutory: Pharma Firms Soon To Choose Between Two UK Pricing Schemes

Executive Summary

The UK’s new voluntary drug pricing and access deal is a “paradigm shift” that will see companies paying different levels of rebates depending on their product mix, with higher payments on older medicines making headroom for growth in newer drugs, according to one lawyer.

You may also be interested in...



Firms Get More Time To Choose Between UK Voluntary & Statutory Drug Pricing Schemes

The final terms of the new voluntary pricing scheme have been published, including six-monthly review meetings and a commitment to look more closely at indication-specific pricing mechanisms.

UK Government Reveals New Statutory Pricing Scheme

The scheme still includes high rebate rates, but a controversial life cycle adjustment mechanism has been dropped.

What’s Next? Five Things To Look Out For In December

Generics Bulletin previews the most noteworthy and anticipated events for December 2023.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS149402

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel